Showing results 1 to 20 of 29
next >
| Issue Date | Title | Author(s) |
| Oct-2021 | All-trans retinoic acid plus high-dose dexamethasone as first-line treatment for patients with newly diagnosed immune thrombocytopenia: a multicentre, open-label, randomised, controlled, phase 2 trial | Huang, Qiu-Sha; Liu, Yi; Wang, Jing-Bo; Peng, Jun; Hou, Ming; Liu, Hui; Feng, Ru; Wang, Jing-Wen; Xu, Lan-Ping; Wang, Yang; Huang, Xiao-Jun; Zhang, Xiao-Hui |
| 2013 | Arsenic trioxide induces apoptosis in B-cell chronic lymphocytic leukemic cells through down-regulation of survivin via the p53-dependent signaling pathway | Zhang, Xiao-Hui; Feng, Ru; Lv, Meng; Jiang, Qian; Zhu, Hong-Hu; Qing, Ya-Zhen; Bao, Jia-Ling; Huang, Xiao-Jun; Zheng, X. Long |
| 2-Nov-2023 | Biomarker MSC-C5b-9-Guided Master Therapies for Resistant/Recurrent ITP: A Prospective, Randomized, Open-Label, Multicenter Trial | Li, Menglin; Fu, Haixia; Liu, Yi; Liu, Hui; Feng, Ru; Wang, Zhao; Wang, Jingwen; Chen, Yuxiu; Qu, Qingyuan; Xiao, Mengyu; Zhou, Jianying; He, Yun; Zhu, Xiaolu; Kong, Yuan; Chang, Yingjun; Liu, Kaiyan; Zhang, Xiaohui |
| 26-Jul-2022 | Developing and validating a mortality prediction model for ICH in ITP: a nationwide representative multicenter study | Chong, Shan; Zhao, Peng; Huang, Rui-Bin; Zhou, Hu; Zhang, Jia-Ning; Hou, Ming; Liu, Yi; Yao, Hong-Xia; Niu, Ting; Peng, Jun; Jiang, Ming; Han, Yan-Qiu; Hu, Jian-Da; Zhou, Ze-Ping; Qiu, Lin; Zhang, Lian-Sheng; Wang, Xin; Wang, Hua-Quan; Feng, Ru; Yang, Lin-Hua; Ma, Liang-Ming; Wang, Shun-Qing; Kong, Pei-Yan; Wang, Wen-Sheng; Sun, Hui-Ping; Sun, Jing; Zhou, He-Bing; Zhu, Tie-Nan; Wang, Li-Ru; Zhang, Jing-Yu; Huang, Qiu-Sha; Fu, Hai-Xia; Wu, Ye-Jun; Li, Yue-Ying; Wang, Qian-Fei; Jiang, Qian; Jiang, Hao; Lu, Jin; Huang, Xiao-Jun; Zhang, Xiao-Hui |
| 2019 | Dysregulated megakaryocyte distribution associated with nestin(+) mesenchymal stem cells in immune thrombocytopenia | Wang, Min; Feng, Ru; Zhang, Jia-min; Xu, Lin-lin; Feng, Fei-er; Wang, Chen-cong; Wang, Qian-ming; Zhu, Xiao-lu; He, Yun; Xue, Jing; Fu, Hai-xia; Lv, Meng; Kong, Yuan; Chang, Ying-jun; Xu, Lan-ping; Liu, Kai-yan; Huang, Xiao-jun; Zhang, Xiao-hui |
| Aug-2020 | The efficacy and safety of Geptanolimab (GB226) in patients with relapsed/refractory peripheral T cell lymphoma (PTCL): A multicenter, open-label, single-arm, phase 2 trial | Shi, Yuankai; Wu, Jianqiu; Wang, Zhen; Zhang, Liling; Wang, Zhao; Zhang, Mingzhi; Cen, Hong; Peng, Zhigang; Li, Yufu; Fan, Lei; Guo, Ye; Ma, Liping; Cui, Jie; Gao, Yuhuan; Yang, Haiyan; Zhang, Hongyu; Wang, Lin; Zhang, Weihua; Zhang, Huilai; Xie, Liping; Jiang, Ming; Zhou, Hui; Shuang, Yuerong; Su, Hang; Ke, Xiaoyan; Jin, Chuan; Du, Xin; Du, Xin; Liu, Li; Xi, Yaming; Ge, Zheng; Feng, Ru; Zhang, Yang; Zhou, Shengyu; Xie, Fan; Gao, Chao |
| 2016 | Helicobacter pylori infection influences the severity of thrombocytopenia and its treatment response in chronic hepatitis B patients with compensatory cirrhosis: A multicenter, observational study | Zhang, Xiao-Hui; He, Yun; Feng, Ru; Xu, Lan-Ping; Jiang, Qian; Jiang, Hao; Lu, Jin; Fu, Hai-Xia; Liu, Hui; Wang, Jing-Wen; Wang, Qian-Ming; Feng, Fei-Er; Zhu, Xiao-Lu; Xu, Lin-Lin; Xie, Yang-Di; Ma, Hui; Wang, Hao; Liu, Kai-Yan; Huang, Xiao-Jun |
| 21-Jul-2023 | IGH rod-like tracer: An AlphaFold2 structural similarity extraction-based predictive biomarker for MRD monitoring in pre-B-ALL | Zhuo, Zhongling; Wang, Qingchen; Li, Chang; Zhang, Lili; Zhang, Lanxin; You, Ran; Gong, Yan; Hua, Ying; Miao, Linzi; Bai, Jiefei; Zhang, Chunli; Feng, Ru; Chen, Meng; Su, Fei; Qu, Chenxue; Xiao, Fei |
| 2015 | IL-35 inhibits acute graft-versus-host disease in a mouse model | Zhang, Xiao-Hui; Zhou, Yi; Zhang, Jia-Min; Zhou, Shi-Yuan; Wang, Min; Feng, Ru; Feng, Fer-Er; Wang, Qian-Ming; Zhu, Xiao-Lu; Zhao, Xiao-Su; Lv, Meng; Kong, Yuan; Chang, Ying-Jun; Huang, Xiao-Jun |
| May-2023 | Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase | Yang, Sen; Zhang, Xiaoshuai; Gale, Robert Peter; Du, Xin; Chen, Chun-yan; Weng, Jian-yu; Huang, Jian; Li, Fei; Zeng, Yun; Xiao, Zhen; Hu, Jian-da; Yang, Li-jie; Liu, Zhuo-gang; Li, Guo-hui; Sun, Xiu-li; Yang, Wei; Feng, Ru; Han, Yan-qiu; Jing, Yu; Xu, Na; Liu, Xiao-li; Liu, Zhen-fang; Wang, Xiao-dong; Wu, Shi-xin; Liang, Rong; Zhang, Yan-li; Yang, Yun-fan; Zhu, Huan-ling; Pan, Ling; Meng, Li; Zhao, Yan-hong; Yi, Hai; Liu, Yi-lan; Zhang, Wei-hua; Zheng, Yuan-jun; Zhou, Ze-ping; Chen, Su-ning; Qiu, Hui-ying; Li, Wei-ming; Jia, Zhi-lin; Bai, Yan-liang; Lin, Li-e; Liu, Bing-cheng; Liu, Chun-shui; Luo, Jian-min; Meng, Jun-xia; Sun, Zhi-qiang; Zhang, Yan-qing; Huang, Xiao-jun; Jiang, Qian |
| 2014 | Immunosuppressive Treatment Combined with Nucleoside Analogues Is Superior to Nucleoside Analogues Alone in the Treatment of Severe Thrombocytopenia in Patients with Cirrhosis-Associated with Hepatitis B in China: A Multicenter, Observational Stu | Zhang, Xiao-Hui; Feng, Ru; Xu, Lan-ping; Jiang, Qian; Jiang, Hao; Fu, Hai-xia; Liu, Hui; Niu, Ting; Wang, Xin; Hu, Jian-da; Jiang, Ming; Wang, Zhao; Wang, Jing-wen; Ma, Hui; Xie, Yan-di; Zhu, Xiao-lu; Wang, Hao; Wei, Lai; Huang, Xiao Jun |
| 2016 | Increased prostacyclin levels inhibit the aggregation and activation of platelets via the PI3K-AKT pathway in prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation | Zhang, Xiao-Hui; Zhou, Shi-Yuan; Feng, Ru; Wang, Ya-Zhe; Kong, Yuan; Zhou, Yi; Zhang, Jia-Min; Wang, Min; Zhao, Jing-Zhong; Wang, Qian-Ming; Feng, Fei-Er; Zhu, Xiao-Lu; Wang, Feng-Rong; Wang, Jing-Zhi; Han, Wei; Chen, Huan; Xu, Lan-Ping; Liu, Yan-Rong; Liu, Kai-Yan; Huang, Xiao-Jun |
| 2-Nov-2023 | Indirect Comparison of Efficacy of Zanubrutinib Versus Orelabrutinib in Patients with Relapsed or Refractory Mantle Cell Lymphoma (R/R MCL): An Updated Analysis with Long-Term Follow up | Song, Yuqin; Zhou, Keshu; Li, Dengju; Hu, Jianda; Zou, Dehui; Gao, Sujun; Yang, Haiyan; Zhang, Huilai; Ji, Jie; Xu, Wei; Feng, Ru; Jin, Jie; Lyu, Fangfang; Fang, Cheng; Xu, Sheng; Zhu, Jun |
| 2023 | Indirect comparisons of efficacy of zanubrutinib versus orelabrutinib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma or relapsed or refractory mantle cell lymphoma | Song, Yuqin; Zhou, Keshu; Yang, Shenmiao; Hu, Jianda; Zou, Dehui; Gao, Sujun; Pan, Ling; Wang, Tingyu; Yang, Haiyan; Zhang, Huilai; Zhou, Daobin; Ji, Jie; Xu, Wei; Feng, Ru; Jin, Jie; Lv, Fangfang; Huang, Haiwen; Fan, Xiaosi; Xu, Sheng; Zhu, Jun |
| 20-Apr-2023 | Lenalidomide or bortezomib as maintenance treatment remedy the inferior impact of high-risk cytogenetic abnormalities in non-transplant patients with newly diagnosed multiple myeloma: a real-world multi-centered study in China | Zhuang, Zhe; Tian, Ying; Shi, Lei; Zou, Dongmei; Feng, Ru; Tian, Wei-wei; Yu, Hong; Dong, Fei; Liao, Aijun; Ma, Yanping; Liu, Qinhua; Liu, Shuangjiao; Jing, Hongmei; Fu, Rong; Ma, Liang-ming; Liu, Hui; Sun, Wanling; Bao, Li; Wu, Yin; Chen, Wenming; Zhuang, Junling |
| 2023 | Long-term outcomes of second-line versus later-line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis | Song, Yuqin; Zhou, Keshu; Zou, Dehui; Li, Dengju; Hu, Jianda; Yang, Haiyan; Zhang, Huilai; Ji, Jie; Xu, Wei; Jin, Jie; Lv, Fangfang; Feng, Ru; Gao, Sujun; Zhou, Daobin; Tam, Constantine S.; Simpson, David; Wang, Michael; Phillips, Tycel J.; Opat, Stephen; Fang, Cheng; Sun, Shaohui; Zhu, Jun |
| 15-Nov-2022 | Long-Term Outcomes of Second-Line Vs Later-Line Zanubrutinib Treatment in Patients with Relapsed/Refractory MCL: An Updated Pooled Analysis | Song, Yuqin; Zhou, Keshu; Zou, Dehui; Li, Dengju; Hu, Jianda; Yang, Haiyan; Zhang, Huilai; Ji, Jie; Xu, Wei; Jin, Jie; Lv, Fangfang; Feng, Ru; Gao, Sujun; Zhou, Daobin; Tam, Constantine S.; Simpson, David; Wang, Michael L.; Phillips, Tycel J.; Opat, Stephen; Fang, Cheng; Sun, Shaohui; Zhu, Jun |
| 4-Nov-2021 | A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China | Liu, Weiping; Zhao, Donglu; Liu, Ting; Niu, Ting; Song, Yongping; Xu, Wei; Jin, Jie; Cai, Qingqing; Huang, Huiqiang; Li, Zhiming; Hou, Ming; Zhang, Huilai; Zhou, Jianfeng; Hu, Jianda; Shen, Jianzhen; Shi, Yuankai; Yang, Yu; Zhang, Liling; Zhao, Weili; Ding, Kaiyang; Qiu, Lugui; Tan, Huo; Zhang, Zhihui; Liu, Lihong; Wang, Jinghua; Xu, Bing; Zhou, Hui; Gao, Guangxun; Xue, Hongwei; Bai, Ou; Feng, Ru; Huang, Xiaobing; Yang, Haiyan; Yan, Xiaojing; Zeng, Qingshu; Liu, Peng; Li, Wenyu; Mao, Min; Su, Hang; Wang, Xin; Xu, Jingyan; Zhou, Daobin; Zhang, Hongyu; Ma, Jun; Shen, Zhixiang; Zhu, Jun |
| 2017 | Oral all-trans retinoic acid plus danazol versus danazol as second-line treatment in adults with primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial | Feng, Fei-Er; Feng, Ru; Wang, Min; Zhang, Jia-Min; Jiang, Hao; Jiang, Qian; Lu, Jin; Liu, Hui; Peng, Jun; Hou, Ming; Shen, Jian-Liang; Wang, Jing-Wen; Xu, Lan-Ping; Liu, Kai-Yan; Huang, Xiao-Jun; Zhang, Xiao-Hui |
| Mar-2021 | Prediction of postpartum hemorrhage in pregnant women with immune thrombocytopenia: Development and validation of the MONITOR model in a nationwide multicenter study | Huang, Qiu-Sha; Zhu, Xiao-Lu; Qu, Qing-Yuan; Liu, Xiao; Zhang, Gao-Chao; Su, Yan; Chen, Qi; Liu, Feng-Qi; Sun, Xue-Yan; Liang, Mei-Ying; Liu, Yi; Jiang, Ming; Liu, Hui; Feng, Ru; Yao, Hong-Xia; Zhang, Lei; Qian, Shen-Xian; Yang, Tong-Hua; Zhang, Jing-Yu; Shen, Xu-Liang; Yang, Lin-Hua; Hu, Jian-Da; Huang, Ren-Wei; Jiang, Zhong-Xing; Wang, Jing-Wen; Zhang, Hong-Yu; Xiao, Zhen; Zhan, Si-Yan; Liu, Hui-Xin; Chang, Ying-Jun; Jiang, Qian; Jiang, Hao; Lu, Jin; Xu, Lan-Ping; Zhang, Xiao-Hong; Yin, Cheng-Hong; Wang, Jian-Liu; Huang, Xiao-Jun; Zhang, Xiao-Hui |
